FDA Cites Pneumex in Warning Letter

A July inspection resulted in these conclusions.

By: Editor

NULL

The FDA has cited rehabilitation equipment manufacturer Pneumex in a December warning. These conclusions are based on a July inspection at the Idaho plant:

 • Failure to implement design and development plans for the Vibro-Trac table

• Failure to document or approve design input requirements for the Vibro-Trac table

• Failure to maintain production records on the Pneu-Back Chair since 2004

• Failure to perform “quality audits” on any devices since 2004

• Failure to designate an individual to review and approve documents 

See the warning letter at compliancefda.com/ShowExternHTML.aspF=CFDAs7061c&src=RSS.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters